118 results
8-K/A
EX-99.1
SLNO
Soleno Therapeutics Inc
10 Apr 17
Other Events
12:00am
740, Income Taxes, using the asset and liability method. The objective of the asset and liability method is to establish deferred tax assets … and liabilities for the temporary differences between the financial reporting basis and the tax basis for the Company’s assets and liabilities at enacted tax
424B5
SLNO
Soleno Therapeutics Inc
6 May 24
Prospectus supplement for primary offering
4:58pm
Income Tax Consequences To Non-U.S. Holders
S-18
Underwriting
S-25
Legal Matters
S-32
Experts
S-32
Where You Can Find More Information
S-32
Incorporation … outstanding.
S-17
MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS
The following discussion describes the material U.S. federal income tax
424B5
SLNO
Soleno Therapeutics Inc
30 Mar 22
Prospectus supplement for primary offering
5:21pm
ARE OFFERING
S-64
MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR NON-U.S. HOLDERS OF OUR COMMON STOCK, PRE-FUNDED WARRANTS AND COMMON WARRANTS
S-67 … and regulations such as tax laws, export and import restrictions, employment laws, regulatory requirements and other governmental approvals, permits
424B5
SLNO
Soleno Therapeutics Inc
2 May 24
Prospectus supplement for primary offering
4:04pm
S-12
Use of Proceeds
S-13
Dividend Policy
S-14
Dilution
S-15
Description of The Securities We Are Offering
S-17
Material U.S. Federal Income Tax … shares of common stock outstanding.
S-17
MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS
The following discussion describes
8-K
EX-99.1
n88 yicmdtml3ce16
18 Mar 19
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
4:37pm
424B5
coimuqcwv4h rppv
23 Jun 20
Prospectus supplement for primary offering
4:06pm
424B3
kc60yqdxhj53xrza500
24 Jul 17
Prospectus supplement
12:00am
424B5
vd2dj9ej7l2
28 Mar 22
Prospectus supplement for primary offering
4:53pm
424B5
klv3x
27 Sep 23
Prospectus supplement for primary offering
5:26pm
S-1/A
EX-10.5
j0t442urk0 aps63
1 Jul 14
IPO registration (amended)
12:00am
8-K
EX-10.1
e3twemqvzr
30 Dec 21
Entry into a Material Definitive Agreement
4:37pm